Occudo Quantitative Strategies LP Anavex Life Sciences Corp. Transaction History

Occudo Quantitative Strategies LP

  • $549 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.55 - $9.37 $269,912 - $386,118
41,208 Added 215.97%
60,288 $394,000
Q2 2023

Aug 14, 2023
BUY
$7.66 - $9.5 $146,152 - $181,260
19,080 New
19,080 $155,000
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $766,806 - $1.11 Million
86,158 New
86,158 $889,000

Others Institutions Holding AVXL

# of Institutions
159
Shares Held
31.6M
Call Options Held
910K
Put Options Held
1.35M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $352M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email